Joseph R. Young
Senior VP of Finance & Chief Accounting OfficerMr. Joseph Young, also known as Joe, M.B.A. is Senior Vice President of Finance at Vera Therapeutics, Inc. since March 2021 and serves as its Chief Accounting Officer since May 2021. From April 2006 to July 2020, Mr. Young held a number of senior leadership roles at Plexxikon Inc., a biotechnology company, and wholly-owned subsidiary of Daiichi-Sankyo Co., Ltd. since its acquisition of Plexxikon in 2011, including most recently Senior Vice President, Finance and Treasurer, where he was responsible for all accounting, finance and treasury operations, in addition to oversight of other business functions. From August 2005 to April 2006, Mr. Young served as Associate Director, Internal Controls Compliance at VaxGen, Inc., a biotechnology company. From February 1999 to August 2005, Mr. Young held management roles at Cerus Corporation, a biotechnology company, including most recently Controller. From October 1994 to January 1999, Mr. Young was an auditor at Ernst & Young LLP. Mr. Young received a B.A. in Business-Economics from the University of California, Los Angeles and an M.B.A. from the University of California, Berkeley—Haas School of Business, and is a Certified Public Accountant (inactive status).
Positions
- Company NameVera Therapeutics, Inc.Stock CodeVERAPositionSenior VP of Finance & Chief Accounting OfficerColleagues
- MWMarshall W. FordyceFounder, President, CEO & Director
- MMMichael M. MorrisseyIndependent Chairman of the Board
- SPSean P. GrantChief Financial Officer
- DLDavid L. JohnsonChief Opearating Officer
- RMRobert M. BrennerChief Medical Officer
- ACAndrew ChengIndependent Director
- SWScott William MorrisonIndependent Director
- PGPatrick Gerald EnrightIndependent Director
